Provided by Tiger Trade Technology Pte. Ltd.

NeuBase Therapeutics Inc.

0.3780
0.0000
Volume:- -
Turnover:- -
Market Cap:1.42M
PE:-0.03
High:0.3780
Open:0.3780
Low:0.3780
Close:0.3780
52wk High:0.3780
52wk Low:0.3780
Shares:3.75M
Float Shares:3.32M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.0087
EPS(LYR):-20.7937
ROE:-93.46%
ROA:-43.03%
PB:0.10
PE(LYR):-0.02

Loading ...

Jul 16, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 16, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 16, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Major Issues Report

Current report, items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01
Jul 11, 2019

Major Issues Report

[Amend] Current report, items 5.07, 8.01, and 9.01
Jul 11, 2019

Business Combinations

Prospectuses and communications, business combinations
Jul 10, 2019

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
Jul 10, 2019

Business Combinations

Prospectuses and communications, business combinations
Jul 08, 2019

Business Combinations

Prospectuses and communications, business combinations
Jul 03, 2019

Business Combinations

Prospectuses and communications, business combinations
Jul 03, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Jul 02, 2019

Business Combinations

Prospectuses and communications, business combinations
Jun 05, 2019

Correspondence

[Cover]Correspondence
May 22, 2019

Correspondence

[Cover]Correspondence
May 15, 2019

Business Combinations

Prospectuses and communications, business combinations
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 15, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
May 07, 2019

Correspondence

[Cover]Correspondence
Apr 16, 2019

Correspondence

[Cover]Correspondence